Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 163,832 shares at $8.61 ($1.4M) on 2021-06-01, disclosed to the SEC on 2021-06-03.
Open-market sale of $1.4M PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.61 | 19,701 | $170K | 12.2% |
| 2 | $8.61 | 19,701 | $170K | 12.2% |
| 3 | $8.61 | 21,493 | $185K | 13.3% |
| 4 | $8.61 | 21,493 | $185K | 13.3% |
| 5 | $8.34 | 19,476 | $162K | 11.7% |
| 6 | $8.34 | 19,476 |
| $162K |
| 11.7% |
| 7 | $8.34 | 21,246 | $177K | 12.8% |
| 8 | $8.34 | 21,246 | $177K | 12.8% |
| Total | $8.48 avg | 163,832 | $1.4M | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |